Inventor · disambiguated record
Matthew Mcneill
Also filed as: MCNEILL MATTHEW · MCNEILL MATTHEW H
5 granted patents·10 pending applications·16 citations·filing 2005–2025
73Inventor score
Files withINTEGRATED DNA TECH INC5LIGAND PHARM INC3TREELINE BIOSCIENCES INC3LELAIS GERALD2CHANG EDCON1
Top patents by PatentIndex Score
15 records- 0184US7314887B2Thrombopoietin activity modulating compounds and methodsLIGAND PHARM INC·Filed 2005·Granted Jan 1, 2008·10 cites·37 claims
- 0278US12254959B2Identification, characterization, and quantitation of CRISPR-introduced double-stranded DNA break repairsINTEGRATED DNA TECH INC·Filed 2020·Granted Mar 18, 2025·1 cites·9 claims
- 0369US9440957B2Compounds and compositions for modulating EGFR ActivityLELAIS GERALD·Filed 2013·Granted Sep 13, 2016·3 cites·21 claims
- 0469US8921358B2Apoptosis signal-regulating kinase 1 inhibitorsTAKEDA PHARMACEUTICAL·Filed 2013·Granted Dec 30, 2014·2 cites·32 claims
- 0568US2024287091A1Tricyclic quinolone bcl6 bifunctional degradersTREELINE BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 0668US2025276981A1Tricyclic quinolone bcl6 bifunctional degradersTREELINE BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 0765US2025218536A1Identification, characterization, and quantitation of crispr-introduced double-stranded dna break repairsINTEGRATED DNA TECH INC·Filed 2025·Application pending·0 cites
- 0864US2023366020A1Use of unique molecular identifiers for improved accuracy of long read sequencing and characterization of crispr editingINTEGRATED DNA TECH INC·Filed 2023·Application pending·0 cites
- 0963US2022025365A1METHODS FOR NOMINATION OF NUCLEASE ON-/OFF-TARGET EDITING LOCATIONS, DESIGNATED "CTL-seq" (CRISPR Tag Linear-seq)INTEGRATED DNA TECH INC·Filed 2021·Application pending·0 cites
- 1063US2025257352A1METHODS FOR NOMINATION OF NUCLEASE ON-/OFF-TARGET EDITING LOCATIONS, DESIGNATED "CTL-seq" (CRISPR Tag Linear-seq)INTEGRATED DNA TECH INC·Filed 2025·Application pending·0 cites
- 1160US2025270191A1Quinolone bcl6 bifunctional degradersTREELINE BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 1256US7691895B2Thrombopoietin activity modulating compounds and methodsLIGAND PHARM INC·Filed 2007·Granted Apr 6, 2010·0 cites·20 claims
- 1356US2008103190A1Thrombopoietin activity modulating compounds and methodsLIGAND PHARM INC·Filed 2007·Application pending·0 cites
- 1445US2009005375A1Acetyl coenzyme a carboxylase inhibitorsCHANG EDCON·Filed 2008·Application pending·0 cites
- 1538US2015152083A1Compounds and Compositions for Modulating EGFR ActivityLELAIS GERALD·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Matthew Mcneill files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →